Course Description: This webinar will discuss the upcoming changes to the CAP guidelines for HER2, and its use in organ systems other than breast cancer.
Presenter Bio: Dr. Yaziji is the founder and Medical Director of Vitro, and is an Adjunct Clinical Professor at the University of Texas, MD Anderson Cancer Center. Among his many professional experiences and accomplishments are numerous research studies, resulting in the publication of 47 peer-reviewed scienti?c articles on topics including applied immunohistochemistry and HER-2 testing by FISH. He is a regular speaker at national and international pathology meetings and believes passionately in the importance of point-of-care-pathology for providing high quality diagnostic results.
Additional Information: This course was presented in July 2016 as part of the NSH IHC/Molecular Webinar Series.